VIDO - Solutions Through Research
  Search the VIDO Site:  

    Site Map     Contact Us 
Home
About Us
InterVac
Research
Information for Producers
VIDO News
Features
Media Contact
In the Media
Resources
Join Mailing List
Patents
Publications
Careers & Training
Contract R&D/Services



Canadian researchers develop E.coli vaccine for cattle: Vaccine could significantly reduce human disease and associated E. coli outbreaks

OTTAWA (Dec. 15, 2003) - Canadian health researchers at the University of British Columbia and the University of Saskatchewan have developed a vaccine that significantly reduces the level of Escherichia coli 0157:H7 (E. coli) in cattle. The vaccine will help to reduce the dramatic economic and healthcare costs associated with E. coli 0157, the toxic microbe responsible for hamburger disease, recalls of contaminated meat, and water contamination.

The full release is available at:
http://www.cihr-irsc.gc.ca/e/news/19939.shtml

 


Home · About Us · InterVac · Research · Information for Producers · VIDO News · Patents
Publications · Careers & Training · Contract R&D/Services